NFL Biosciences SAS (ALNFL) — Free Cash Flow Generation Index
Latest as of June 2023:
1.00x
NFL Biosciences SAS (ALNFL) has a Free Cash Flow Generation Index of 1.00x as of June 2023. Free cash flow of €57.51K represents 1% of operating cash flow (€57.51K). Read NFL Biosciences SAS debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
1.00x
Free Cash Flow / Operating CF
Free Cash Flow
€57.51K
EUR
Operating Cash Flow
€57.51K
EUR
Capital Expenditures
€0.00
EUR
NFL Biosciences SAS Free Cash Flow Generation Index (2020–2022)
Historical FCF Generation Index trend for NFL Biosciences SAS across 3 annual periods.
Annual Free Cash Flow Generation for NFL Biosciences SAS (2020–2022)
Year-by-year Free Cash Flow Generation Index for NFL Biosciences SAS. For the full company profile including market capitalisation, see ALNFL stock market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.00x | €104.89K | €104.89K | €0.00 | ▲ +0.0% |
| 2021 | 1.00x | €87.00K | €87.00K | €0.00 | ▲ +0.0% |
| 2020 | 1.00x | €83.91K | €83.91K | €0.00 | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).